跳至主要内容
临床试验/JPRN-UMIN000011152
JPRN-UMIN000011152招募中未知

Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomas - B-SRIM Study

B-SRIM Study Group0 个研究点目标入组 38 人开始时间: 2013年7月11日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who are pregnant or in the location period, and who are not able to, or not willing to prevent conception during the therapeutic period of this clinical study 2. Patients who have coinciding active cancer 3. Patients who have psychiatric disorder 4. Patients who have circulating lymphoma cells >= 25,000 /uL in peripheral blood 5. Patients who have interstitial pneumonia or pulmonary fibrosis 6. Patients who have central nerve system lymphoma 7. Patients who have severe allergic reaction to medication 8. Patients who are considered as inappropriate to register by physician

研究者

发起方
B-SRIM Study Group

相似试验

Phase II study to evaluate efficacy and safety of... | 临床试验